12:00 AM
 | 
Oct 08, 2012
 |  BC Week In Review  |  Company News  |  Deals

Bristol-Myers, Sanofi deal

Sanofi and Bristol-Myers restructured a 1993 co-promotion deal for three cardiovascular drugs - Plavix clopidogrel, Avapro irbesartan and Avalide irbesartan/hydrochlorothiazide - following the drugs' loss of exclusivity in the U.S. this year. Effective Jan. 1, 2013, Bristol-Myers will return to Sanofi worldwide rights to the drugs, excluding rights for Plavix in the U.S. and Puerto Rico, where...

Read the full 292 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >